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Introduction {#sec005}
============

In recent years, the number of new HIV infections per year and the number of PLWHA have continued to increase in China \[[@pone.0201177.ref001]\]. Data suggest that the number of newly diagnosed cases has increased rapidly each year from 20,450 in 2011 to 45,145 in 2014 \[[@pone.0201177.ref002],[@pone.0201177.ref003]\]. By the end of 2014, 501,000 cases of PLWHA, including 296,000 people living with HIV and 205,000 AIDS patients, had been reported based on the China Information System for Disease Control and Prevention \[[@pone.0201177.ref004]\]. Since 2003, free highly active antiretroviral treatment (HAART) has been provided to patients who agree with the conditions of treatment as a response to the HIV/AIDS epidemic in China \[[@pone.0201177.ref005]\]. Advances in treatment have improved survival rates in HIV-infected individuals, and AIDS has been shifted from a fatal disease to a chronic illness \[[@pone.0201177.ref006]\]. The result is that persons living with HIV are more likely to experience deteriorating physical health and psychological stress \[[@pone.0201177.ref007],[@pone.0201177.ref008]\]. An important goal in the treatment of HIV-infected patients is, therefore, the effective enhancement of the quality of life (QOL) \[[@pone.0201177.ref009]\].

The body of literature on the measurement of QOL of PLWHA is growing \[[@pone.0201177.ref010]--[@pone.0201177.ref017]\]. QOL measures have been used to assess the physical and mental conditions of PLWHA, evaluate the effectiveness of treatment and intervention programs, identify the need for health services improvements, and investigate factors predicting well-being in PLWHA. QOL measures have become increasingly important and are receiving increasing attention.

Several QOL instruments have been applied in the evaluation of HIV-infected patients \[[@pone.0201177.ref018]--[@pone.0201177.ref021]\]. Each questionnaire has a unique structure and advantages. Among four HIV-specific QOL instruments, MOS-HIV demonstrated more satisfactory results based on the evaluation criteria in the review by Davis and colleagues \[[@pone.0201177.ref022]\]. The MOS-HIV measures three domains (cognitive functioning, health distress and quality of life) hypothesized to be associated with the health deterioration associated with HIV disease that are not measured by the SF-36 which is the commonly used measure in a wide variety of patient populations \[[@pone.0201177.ref018]\]. The MOS-HIV allows for the calculation of both individual scale and summary scores that permit more specific identification to be derived regarding the domains of Health-related quality of life (HRQOL) that are affected by HIV infection, AIDS, and/or its treatment and has become a popular instrument for measuring HRQOL of PLWHA.

Due to its brevity and comprehensiveness, various versions of the MOS-HIV have been translated into different languages. Studies have demonstrated that the reliability and validity of the versions of the MOS-HIV that have been translated into different languages and adapted for different cultures remain good in the PLWHA \[[@pone.0201177.ref021], [@pone.0201177.ref023]--[@pone.0201177.ref025]\]. Relatively few studies have been conducted to evaluate the QOL of PLWHA living in mainland China using the MOS-HIV. Thus, in this study, our aim was to test the reliability and validity of the MOS-HIV questionnaire to provide preliminary information for potential applications of the MOS-HIV in Chinese PLWHA.

Materials and methods {#sec006}
=====================

Respondents and procedures {#sec007}
--------------------------

A cross-sectional study was conducted in three cities (Dalian, Ningbo, and Zhengzhou) located in Liaoning province, Henan province, and Zhejiang province, respectively. The inclusion criteria were as follows: aged 18 years or older, infected with HIV, be capable of reading Chinese. Respondents unable to complete an interview and respondents unable to provide consent were excluded. A total of 646 PLWHA were recruited from the local Centers for Disease Control and Prevention (CDC) and infectious diseases hospitals between May 2015 and March 2016. Written informed consent was obtained from each respondent before survey initiation. Participation in the study was completely voluntary. All of the respondents completed a self-report questionnaire, and after survey completion, 50 Yuan (equivalent to 10 US dollars) was given to respondents as compensation for their time.

The questionnaire included the background information (age, gender, marital status, education, monthly income, CD4 count, HIV-related symptoms) and a Chinese simplified version of MOS-HIV, which was translated by professor Fen Yang \[[@pone.0201177.ref026]\]. The MOS-HIV includes 35 items and measures 10 scales, including 8 multi-items (general health, physical function, role function, cognitive function, pain, mental health, energy/fatigue and health distress) and 2 single items (social function and quality of life). Additionally, there was a single item named health transition. These ten scales can be effectively calculated under two summary scale scores, the PHS and the MHS, with the physical functioning, pain and role functioning scales contributing to the PHS, the mental health, health distress, quality of life and cognitive function scales contributing to the MHS, and the energy/fatigue, general health and social functioning contributing to both factors \[[@pone.0201177.ref026],[@pone.0201177.ref027]\]. The raw scores for each scale were transformed to a scale of 0--100, with higher scores indicating 'better' QOL \[[@pone.0201177.ref028]\].

After the respondents completed the questionnaires, specially trained personnel reviewed the questionnaires, determined if the respondents had provided any non-standard or ambiguous answers, and contacted the respondents for timely verification. The study protocol was approved by the bioethics advisory commission of China Medical University (2014\[[@pone.0201177.ref034]\]).

Statistical analysis {#sec008}
--------------------

Descriptive statistics such as the mean score, standard deviation (SD), range and percentage of respondents scoring the floor and ceiling possible scores were generated. The reliability of the MOS-HIV questionnaire was measured in terms of internal consistency, which was expressed as Cronbach's α coefficient. Reliability was considered to be adequate if the α value was \>0.7. Test-retest reliability was assessed using Pearson's correlation coefficient to determine the consistency of the questionnaire when administered two different times. To evaluate this construct, 60 randomly selected study subjects completed the questionnaire again 2 weeks later. Validity was analyzed in terms of convergent validity, discriminant validity, construct validity and known group validity. Convergent validity was assessed by correlation coefficients between each item and each scale to which they belong (General health; Physical function; Role function; Cognitive function; Pain; Mental health; Energy/fatigue; Health distress). Convergent validity was considered good if the coefficient for the correlation between each item and its related scales was \>0.4. To demonstrate discriminant validity, items should be more highly correlated with their hypothesized scales than with the scales measuring other concepts. Confirmatory factor analyses (CFA) were used to test construct validity. Model fit was evaluated by examining the comparative fit index (CFI), non-normed fit index (NNFI), adjusted goodness-of-fit index (AGFI), standardized root mean squared residual (SRMR), and root-mean-square error of approximation (RMSEA). Conventionally, the model fit is considered acceptable if the CFI, AGFI, and NNFI are each 0.90 or greater. The general cutoff points for the RMSEA index and the SRMR at which a factor model is considered acceptable are below 0.08\[[@pone.0201177.ref029]\]. A multiple-group CFA analysis was conducted to investigate whether the MOS-HIV measured the same constructs across gender groups. First, the configural invariance was assessed. Then metric invariance was assessed by examining if the factor loadings were the same across gender groups. Changes in CFI (ΔCFI ≤ 0.01) were used to demonstrate factorial invariance across groups \[[@pone.0201177.ref030],[@pone.0201177.ref031]\]. Known group comparisons were performed by determining whether individual MOS-HIV scale scores could discriminate among respondents with different CD4 cell counts (below 200 cells/mm^3^, 200 to 500 cells/mm^3^, and 500 cells/mm^3^ and above) and HIV symptoms (symptomatic and asymptomatic) using one-way Analysis of variance (ANOVA) and Student's t-test.

The data were analyzed using SPSS® version 16.0 (SPSS Inc., Chicago, IL, USA) for Windows. CFA was carried out using LISREL 8.7. A *P*-value of \< 0.05 was considered statistically significant.

Results {#sec009}
=======

Background characteristics {#sec010}
--------------------------

Overall, 635 respondents completed the questionnaire, for a response rate of 98.3%. The mean age was 39.2 ± 7.6 years, with a range of 33--64 years. Of the respondents, 447 (70.4%) were men. The respondents' CD4 count levels were as follows: 94 (14.8%) were below 200 cells/mm^3^, 332 (52.3%) were 200 to 500 cells/mm^3^, and 209 (32.9%) were 500 cells/mm^3^ and above. 135 (21.3%) respondents had HIV-related symptoms ([Table 1](#pone.0201177.t001){ref-type="table"}).

10.1371/journal.pone.0201177.t001

###### Distribution of background characteristics.

![](pone.0201177.t001){#pone.0201177.t001g}

  Item                                    Number   \%
  --------------------------------------- -------- -------
  Age (years)                                      
  \<20                                    15       2.4%
  20--30                                  195      30.7%
  30--40                                  158      24.9%
  \>40                                    267      42.0%
  Gender                                           
  Male                                    447      70.4%
  Female                                  188      29.6%
  Marital status                                   
  Single                                  222      35.0%
  Married                                 321      50.6%
  Divorced or widowed                     92       14.4%
  Education level                                  
  Junior high school education or lower   279      43.9%
  Senior high school                      116      18.3%
  College education or greater            240      37.8%
  Monthly income                                   
  \<2000 RMB                              282      44.4%
  2000--4000 RMB                          246      38.7%
  \>4000 RMB                              107      16.9%
  CD4 count (cells/mm^3^)                          
  \<200                                   94       14.8%
  200--500                                332      52.3%
  \>500                                   209      32.9%
  HIV symptoms                                     
  Symptomatic                             135      21.3%
  Asymptomatic                            500      78.7%

Distribution of scores {#sec011}
----------------------

The mean scores ranged from 44.1 to 85.2. The floor effects were not significant, the maximum of which was 9.1% (role function), whereas significant ceiling effects were observed for role function (35.4%), social function (17.8%), and cognitive function (15.7%). The mean MHS score and PHS score were 44.1 (SD = 11.0) and 50.9 (SD = 8.4) with no ceiling or floor effects ([Table 2](#pone.0201177.t002){ref-type="table"}).

10.1371/journal.pone.0201177.t002

###### Distribution of MOS-HIV scale scores.

![](pone.0201177.t002){#pone.0201177.t002g}

  Scales                   No. of items   Mean   SD     \% Floor   %Ceiling
  ------------------------ -------------- ------ ------ ---------- ----------
  General health           5              54.0   19.9   0.8        0.9
  Physical function        6              85.2   18.5   0.9        11.1
  Role function            2              76.6   25.1   9.1        35.4
  Social function          1              65.3   13.3   7.2        17.8
  Cognitive function       4              68.6   26.7   1.1        15.7
  Pain                     2              81.0   20.6   0.5        1.8
  Mental health            5              60.7   19.9   0.2        1.8
  Energy/fatigue           4              57.7   20.1   0.6        3.0
  Health distress          4              65.9   18.1   1.6        1.7
  Quality of life          1              61.1   11.5   2.4        10.7
  Health transition        1              55.3   15.1   4.1        9.8
  Mental health scores     \-             44.1   11.0   0.0        0.0
  Physical health scores   \-             50.9   8.4    0.0        0.0

Reliability analysis {#sec012}
--------------------

The internal consistency reliability of the questionnaire was good. Reliability of the PHS and MHS scales was 0.87 and 0.89, respectively. The Cronbach's α coefficients for the eight multi-item scales ranged from 0.79 to 0.93. Three dimensions (social function, quality of life and health transition) could not be assessed because they each consisted of only one item. The correlations observed between the items indicated that the test-retest reliability was good and that r \> 0.70 could be achieved in all the domains (p\<0.05), demonstrating that the MOS-HIV questionnaire had relatively good stability. The differences between the mean values calculated for each scale after two rounds of measurements were not statistically significant ([Table 3](#pone.0201177.t003){ref-type="table"}).

10.1371/journal.pone.0201177.t003

###### Internal reliability and inter-correlations of the MOS-HIV scales.
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  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Scale\   Test-retest reliability\                    Cronbach'*α* coefficient\          Inter-correlations of the MOS-HIV scales                                                           
           *n* = 60                                    *n* = 635                                                                                                                             
  -------- ------------------------------------------- --------------------------- ------ ------------------------------------------ ------ ------ ------ ------ ------ ------ ------ ------ ---
  GH       0.71[\*](#t003fn002){ref-type="table-fn"}   0.79                        1                                                                                                         

  PF       0.82[\*](#t003fn002){ref-type="table-fn"}   0.87                        0.38   1                                                                                                  

  RF       0.76[\*](#t003fn002){ref-type="table-fn"}   0.80                        0.38   0.45                                       1                                                       

  SF       \-                                          \-                          0.31   0.26                                       0.24   1                                                

  CF       0.82[\*](#t003fn002){ref-type="table-fn"}   0.90                        0.43   0.44                                       0.37   0.51   1                                         

  PN       0.85[\*](#t003fn002){ref-type="table-fn"}   0.88                        0.52   0.37                                       0.50   0.31   0.48   1                                  

  MH       0.79[\*](#t003fn002){ref-type="table-fn"}   0.87                        0.52   0.31                                       0.28   0.35   0.57   0.4    1                           

  EF       0.85[\*](#t003fn002){ref-type="table-fn"}   0.80                        0.61   0.37                                       0.37   0.33   0.48   0.45   0.51   1                    

  HD       0.90[\*](#t003fn002){ref-type="table-fn"}   0.93                        0.45   0.32                                       0.28   0.52   0.43   0.41   0.55   0.49   1             

  QOL      \-                                          \-                          0.50   0.23                                       0.31   0.25   0.39   0.46   0.46   0.43   0.42   1      

  HT       \-                                          \-                          0.28   0.11                                       0.12   0.22   0.24   0.25   0.27   0.28   0.24   0.42   1
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

GH general health, PF physical function, RF role function, SF social function, CF cognitive function, PN pain, MH mental health, EF energy/fatigue, HD health distress, QoL quality of life, HT health transition

\**p*\<0.05

Validity analysis {#sec013}
-----------------

Construct validity was evaluated using confirmatory factor analyses. The results of the factor analysis indicated that when the two component summary scores (PHS and MHS) were extracted from those of the ten scales, physical functioning, pain and role functioning loaded most strongly onto PHS, while mental health, health distress, quality of life and cognitive functioning loaded most strongly onto MHS; energy/fatigue, general health and social functioning contributed to both summary scores ([Table 4](#pone.0201177.t004){ref-type="table"}). The fit index values were as follows: *χ*^2^ = 418.42 (*df* = 31, p\<0.05), RMSEA = 0.04, SRMR = 0.061, NNFI = 0.91, CFI = 0.97, AGFI = 0.93. According to the fit index values, the fit of the hypothesized model was acceptable. The structure of the MOS-HIV was tested across gender groups to evaluate factorial invariance. The results of configural invariance showed the invariance of the factor structure across gender groups: *χ*^2^ = 515.97 (p \< 0.05), RMSEA = 0.041, and CFI = 0.968. The findings for metric invariance showed that the factor loadings were the same across gender groups: *χ*^2^ = 514.29 (p \< 0.05), RMSEA = 0.042, and CFI = 0.969. The change of CFI was 0.001 which was lower than 0.01 suggesting that the Chinese version of the MOS-HIV showed factorial invariance for PLWHA across gender groups.

10.1371/journal.pone.0201177.t004

###### Standardized estimates of factor loading for the hypothesized model.
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  Scales               PHS    MHS
  -------------------- ------ ------
  General health       0.54   0.22
  Physical function    0.77   
  Role function        0.63   
  Pain                 0.62   
  Social function      0.22   0.57
  Mental health               0.73
  Energy/fatigue       0.03   0.79
  Health distress             0.76
  Cognitive function          0.83
  Quality of life             0.75

The convergent validity and item-discriminant validity of the MOS-HIV are shown in [Table 5](#pone.0201177.t005){ref-type="table"}. The coefficients for correlations between items and the hypothesized scale were 0.60--0.94. The correlations were all greater than 0.40, indicating a 'perfect' success rate and a good convergent validity. In addition, an excellent success rate was also achieved in terms of the item-discriminant validity tests. The item-discriminant validity correlations ranged from 0.05 to 0.70. Items were found to be significantly more correlated with their hypothesized scales than with the scales measuring other concepts ([Table 5](#pone.0201177.t005){ref-type="table"}).

10.1371/journal.pone.0201177.t005

###### Convergent validity and discriminant validity of the MOS-HIV.
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                       Coefficient range   Success rate (%)         
  -------------------- ------------------- ------------------ ----- -----
  General health       0.63--0.73          0.09--0.51         100   100
  Physical function    0.60--0.78          0.05--0.40         100   100
  Role function        0.80--0.89          0.08--0.47         100   100
  Social function      \-                  0.22--0.52         \-    100
  Cognitive function   0.84--0.92          0.18--0.70         100   100
  Pain                 0.87--0.88          0.20--0.49         100   100
  Mental health        0.68--0.76          0.12--0.67         100   100
  Energy/fatigue       0.63--0.72          0.10--0.60         100   100
  Health distress      0.89--0.94          0.20--0.68         100   100
  Quality of life      \-                  0.23--0.49         \-    100
  Health transition    \-                  0.11--0.42         \-    100

a:Correlations between items and hypothesized scales after correction for overlap

b:Correlations between items and other scales

Respondents with CD4 counts of more than 500 cells/mm^3^ were found to have better QOL scores on six of the ten scales (general health scale, physical function scale, role function scale, cognitive function scale, pain scale, energy/fatigue scale) and one of the summary scores (PHS) than respondents with lower CD4 counts (those with CD4 counts of less than 200 cells/mm^3^ or 200--500 cells/mm^3^, p\<0.05). Symptomatic respondents had significantly lower scores than asymptomatic respondents on all the scales except health transition scales (p\<0.05). These results indicate that the instrument has good known group validity ([Table 6](#pone.0201177.t006){ref-type="table"} and [Table 7](#pone.0201177.t007){ref-type="table"}).

10.1371/journal.pone.0201177.t006

###### Known group validity of the MOS-HIV scales for different CD4 counts.
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  ----------------------------------------------------------------------------------------------------------
  Scale                    \<200 cells/mm^3^\   200--500 cells/mm^3^\   \>500 cells/mm^3^\   F       P
                           Mean (SD)            Mean (SD)               Mean (SD)                    
  ------------------------ -------------------- ----------------------- -------------------- ------- -------
  General health           47.8(17.5)           54.2(19.7)              56.4(20.5)           6.186   0.002

  Physical function        81.2(21.0)           84.5(18.2)              88.0(17.4)           4.977   0.007

  Role function            68.1(39.4)           75.3(36.1)              82.5(30.1)           6.085   0.002

  Social function          64.3(32.1)           66.0(32.6)              64.6(35.0)           0.159   0.853

  Cognitive function       64.4(28.9)           67.6(26.9)              72.0(25.0)           3.158   0.043

  Pain                     78.0(23.8)           79.7(21.1)              84.6(17.7)           5.008   0.007

  Mental health            59.6(19.5)           59.5(20.3)              63.3(19.2)           2.581   0.076

  Energy/fatigue           55.3(19.5)           56.2(20.6)              61.2(19.1)           4.816   0.008

  Health distress          63.8(29.5)           65.6(28.4)              67.3(27.0)           0.556   0.574

  Quality of life          59.8(19.1)           60.1(22.4)              63.3(21.1)           1.596   0.204

  Health transition        58.0(23.2)           54.4(26.8)              55.5(23.0)           0.736   0.479

  Mental health scores     42.8(11.0)           43.6(11.2)              45.4(10.5)           2.509   0.082

  Physical health scores   48.8(9.0)            50.6(8.4)               52.2(7.7)            5.902   0.003
  ----------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0201177.t007

###### Known group validity of the MOS-HIV scales on the basis of HIV symptoms.
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  **Scale**                **Symptomatic**   **Asymptomatic**   **t**    **P**
  ------------------------ ----------------- ------------------ -------- -------
  general health           50.2(19.0)        55.0(20.0)         -2.496   0.013
  physical function        79.3(22.6)        86.8(16.9)         -4.231   0.000
  role function            62.2(41.6)        80.5(32.0)         -5.494   0.000
  social function          59.4(32.0)        66.8(33.4)         -2.312   0.021
  cognitive function       57.4(28.1)        71.6(25.5)         -5.626   0.000
  pain                     71.2(22.2)        83.7(19.3)         -6.549   0.000
  mental health            56.4(18.2)        61.9(20.1)         -2.891   0.004
  energy                   51.0(19.3)        59.5(19.9)         -4.396   0.000
  health distress          60.6(28.7)        67.3(27.8)         -2.497   0.013
  quality of life          54.8(23.2)        62.8(20.8)         -3.863   0.000
  health transition        53.1(28.0)        55.9(24.2)         -1.131   0.258
  mental health scores     40.6(10.5)        45.0(10.9)         -4.234   0.000
  physical health scores   47.0(9. 1)        51.9(7. 8)         -6.216   0.000

Discussion {#sec014}
==========

As a multidimensional assessment of physical, psychological, and social functions, the MOS-HIV is believed to be a good measure of an individual's state of health; it has become increasingly important and has received increasing attention. The MOS-HIV instrument has been found to be suitable and appropriate to assess QOL of HIV-infected individuals in many countries. The instrument has been reported to have good psychometric properties \[[@pone.0201177.ref006],[@pone.0201177.ref023]--[@pone.0201177.ref025],[@pone.0201177.ref028],[@pone.0201177.ref032]\]. In China, the MOS-HIV questionnaire was also used to assess the quality of life and related influencing factors of PLWHA in Zhejiang, Henan, Shanxi, Guangxi and Yunnan provinces which showed acceptable reliability and validity in general \[[@pone.0201177.ref033],[@pone.0201177.ref034]\]. As identified in other similar international studies, the results of our study indicated that the MOS-HIV had acceptable reliability and validity for determining QOL of Chinese PLWHA.

The degree of internal consistency across the items was expressed via Cronbach's α coefficients. Some studies have reported the identification of lower Cronbach's α coefficients (below 0.70) on some scales of the MOS-HIV. Chariyalertsak et al. reported identifying Cronbach's α coefficients greater than 0.7 for all scales of the MOS-HIV (0.77--0.90) except the physical function subscale (0.67) in HIV-infected homeless and marginally housed individuals \[[@pone.0201177.ref020]\]. Hsiung et al. found that the Cronbach's α coefficients all ranged from 0.82 to 0.95 across the scales of the MOS-HIV in patients with HIV infection except the coefficient for the role function subscale (0.54) \[[@pone.0201177.ref035],[@pone.0201177.ref036]\]. In our study, the Cronbach's α values ranged from 0.79 to 0.93, which indicated that reliability of the MOS-HIV scales were generally good.

In light of distribution of the MOS-HIV scores, three scales (role function (35.4%), social function (17.8%), and cognitive function (15.7%)) showed moderate ceiling effects; similar effects have been previously reported \[[@pone.0201177.ref006], [@pone.0201177.ref037]--[@pone.0201177.ref039]\]. This phenomenon could be in part attributable to the presence of fewer items in the role function, social function, and cognitive function domains \[[@pone.0201177.ref006], [@pone.0201177.ref037]--[@pone.0201177.ref039]\]. The observed ceiling effects may also imply that these scales have weak differentiation capabilities; however, the internal consistency tests confirmed that the items were more highly correlated with their own scales than with others.

Previous studies conducted in PLWHA demonstrated the presence of good construct validity of MOS-HIV \[[@pone.0201177.ref036], [@pone.0201177.ref027], [@pone.0201177.ref040]\]. In our study, the results of the chi-square test (*χ*^2^ = 418.42 and *p*\<0.05) indicated a lack of fit. Hsiung et al. suggested that there was a tendency for the chi-square test to be influenced by sample size. A larger sample size may well have resulted in the derivation of significant results and indicated a lack of fit \[[@pone.0201177.ref035]\]. However, the coefficients for the NNFI (0.91), AGFI (0.93), and CFI (0.97) incremental fit indices were all above 0.90, and the coefficients for the two absolute fit indices (SRMR (0.061) and RMSEA (0.04)) were below 0.08, all of which suggested that the model had acceptable fit, indicating good overall construct validity. The change of CFI was 0.001 which was lower than 0.01 suggested that the Chinese version of the MOS-HIV showed factorial invariance for PLWHA across gender groups. The coefficients for correlations between items and the hypothesized scale were all greater than 0.40, indicating a 'perfect' success rate. In addition, an excellent success rate was also demonstrated by the results of the item-discriminant validity tests. Our results showed that the convergent validity and discriminant validity measures for all scales were satisfactory, representing findings that were consistent with those of previous studies \[[@pone.0201177.ref006], [@pone.0201177.ref035]--[@pone.0201177.ref039]\].

Some studies have suggested that MOS-HIV scores were not associated with CD4 cell count \[[@pone.0201177.ref006], [@pone.0201177.ref039], [@pone.0201177.ref041]--[@pone.0201177.ref043]\]. In contrast, most studies have supported the validity of the MOS-HIV in capturing CD4 cell count differences \[[@pone.0201177.ref023], [@pone.0201177.ref027], [@pone.0201177.ref040], [@pone.0201177.ref041], [@pone.0201177.ref043]--[@pone.0201177.ref048]\]. Based on the results of previous studies, subjects with low CD4 cell count would be expected to score lower on the MOS-HIV scales. In our study, six of the ten scales (general health scale, physical function scale, role function scale, cognitive function scale, pain scale, energy/fatigue scale) and one of the summary scores (PHS) scores demonstrated the ability to discriminate between groups of respondents stratified by CD4 cell counts. Better scores were observed in PLWHA with higher CD4 cell counts. These findings provide further evidence of the good known group validity of the MOS-HIV questionnaire and suggest that it may be a practical tool for use in the monitoring of health status in Chinese PLWHA.

However, we acknowledge that there are some limitations to this study. Study participants were recruited from 3 cities of China, which may have, to some extent, limited the representation of this study sample. Thus, it may have been better to survey a larger sample of PLWHA to increase the generalizability of study results.

Conclusion {#sec015}
==========

The MOS-HIV demonstrated good reliability and acceptable validity in assessing the QOL of Chinese PLWHA. It may serve as a valuable tool in evaluating QOL of Chinese PLWHA.
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